Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ALFA-2A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 326 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vittorio, CC; Rook, AH; French, LE; Shapiro, M; Lehrer, MS; Junkins-Hopkins, JM
      Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma

      BIODRUGS
    2. Garmendia, G; Miranda, N; Borroso, S; Longchong, M; Martinez, E; Ferrero, J; Porrero, P; Lopez-Saura, P
      Regression of infancy hemangiomas with recombinant IFN-alpha 2b

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    3. Wong, SF
      Oral bexarotene in the treatment of cutaneous T-cell lymphoma

      ANNALS OF PHARMACOTHERAPY
    4. Nagasawa, M; Iino, Y; Koibuchi, Y; Andoh, T; Morishita, Y
      Effect of a combined administration of 5-fluorouracil and medroxyprogesterone acetate on pyrimidine nucleoside phosphorylases and thymidylate synthetase in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors

      ONCOLOGY REPORTS
    5. Gibbs, P; Gonzalez, R; Lee, LA; Walsh, P
      Medical management of cutaneous malignancies

      CLINICS IN DERMATOLOGY
    6. Apisarnthanarax, N; Duvic, M
      Cutaneous T-cell lymphoma - New immunomodulators

      DERMATOLOGIC CLINICS
    7. Bajetta, E; Del Vecchio, M; Vitali, M; Martinetti, A; Ferrari, L; Queirolo, P; Sertoli, MR; Cainelli, T; Cellerino, R; Cascinelli, N
      A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma

      TUMORI
    8. Ellis, CN; Krach, KJ
      Uses and complications of isotretinoin therapy

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    9. Margolin, K; Longmate, J; Synold, TW; Gandara, DR; Weber, J; Gonzalez, R; Johansen, MJ; Newman, R; Baratta, T; Doroshow, JH
      Dolastatin-10 in metastatic melanoma: A phase II and pharmokinetic trial of the california cancer consortium

      INVESTIGATIONAL NEW DRUGS
    10. Hillman, JD; Peng, AT; Gilliam, AC; Remick, SC
      Treatment of kaposi sarcoma with oral administration of shark cartilage ina human herpesvirus 8-seropositive, human immunodeficiency virus-seronegative homosexual man

      ARCHIVES OF DERMATOLOGY
    11. Scott, KJ; Greinwald, JH; Darrow, D; Smith, RJH
      Endobronchial tumors in children: An uncommon clinical entity

      ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
    12. Laverdiere, C; David, M; Dubois, J; Russo, P; Hershon, L; Lapierre, JG
      Improvement of disseminated lymphangiomatosis with recombinant interferon therapy

      PEDIATRIC PULMONOLOGY
    13. Fidler, IJ; Singh, RK; Yoneda, J; Kumar, R; Xu, L; Dong, ZY; Bielenberg, DR; McCarty, M; Ellis, LM
      Critical determinants of neoplastic angiogenesis

      CANCER JOURNAL
    14. Sarrafizadeh, R; Trese, MT
      New therapies for the treatment of age-related macular degeneration

      EXPERT OPINION ON THERAPEUTIC PATENTS
    15. Dillman, RO; Soori, G; Wiemann, MC; Schulof, R; Dobbs, TW; Ruben, RH; DePriest, CB; Church, C
      Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    16. Dillman, RO; Beutel, LD; Cornforth, AN; Nayak, SK
      Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    17. Flaherty, LE
      Rationale for intergroup trial E-3695 comparing concurrent biochemotherapyth cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    18. Tsavaris, N; Skarlos, D; Bacoyiannis, C; Aravantinos, G; Kosmas, C; Retalis, G; Panopoulos, C; Vadiaka, M; Dimitrakopoulos, A; Kostantinidis, K; Mitropoulos, D; Bougas, D; Pantazopoulos, D; Kosmidis, P
      Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    19. McDermott, DF; Mier, JW; Lawrence, DP; van den Brink, MRM; Clancy, MA; Rubin, KM; Atkins, MB
      A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma

      CLINICAL CANCER RESEARCH
    20. Hurvitz, SA; Hurvitz, CH; Sloninsky, L; Sanford, MC
      Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    21. Riedel, F; Gotte, K; Bergler, W; Rojas, W; Hormann, K
      Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    22. Tannir, NM; Talpaz, M; Ghazal, H; Proothi, S; Kantarjian, HM
      Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    23. Egan, CA; Zone, JJ
      Hepatitis C and skin disease

      CURRENT PROBLEMS IN DERMATOLOGY-US
    24. Fizazi, K; Caliandro, R; Soulie, P; Fandi, A; Daniel, C; Bedin, A; Doubre, H; Viala, J; Rodier, JM; Trandafir, L; Le Chevalier, T; Cvitkovic, E; Armand, JP; Ruffie, P
      Combination raltitrexed (Tomudex (R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

      EUROPEAN JOURNAL OF CANCER
    25. Schmidinger, M; Steger, GG; Budinsky, AC; Wenzel, C; Brodowicz, T; Locker, GJ; Kramer, G; Marberger, M; Zielinski, CC
      Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma

      ANTI-CANCER DRUGS
    26. Amichai, B; Grunwald, MH
      Isotretinoin in dermatology

      JOURNAL OF DERMATOLOGICAL TREATMENT
    27. Gimal, I; Duveau, E; Enjolras, O; Verret, JL; Ginies, JL
      Treatment of alarming hemangiomas in infancy: efficacy and safety of interferon alpha.

      ARCHIVES DE PEDIATRIE
    28. Wechsler, B; Bodaghi, B; Huong, DLT; Fardeau, C; Amoura, Z; Cassoux, N; Piette, JC; LeHoang, P
      Efficacy of interferon alfa-2a in severe and refractory uveitis associatedwith Behcet's disease

      OCULAR IMMUNOLOGY AND INFLAMMATION
    29. Ulrich, J; Krause, M; Brachmann, A; Franke, I; Gollnick, H
      Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    30. Wolchok, JD; Motzer, RJ
      Management of renal cell carcinoma

      ONCOLOGY-NEW YORK
    31. Cohen, P
      Extrahepatic manifestations of the hepatitis C virus

      PRESSE MEDICALE
    32. Jacobs, A; Gold, P; Weiden, P; Aboulafia, D; Rudolph, R; Picozzi, V; Thompson, J
      Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer

      CANCER INVESTIGATION
    33. Duvic, M; Cather, JC
      Emerging new therapies for cutaneous T-cell lymphoma

      DERMATOLOGIC CLINICS
    34. Al-Sebeih, K; Manoukian, J
      Systemic steroids for the management of obstructive subglottic hemangioma

      JOURNAL OF OTOLARYNGOLOGY
    35. Schmidinger, M; Steger, GG; Wenzel, C; Locker, GJ; Brodowicz, T; Budinsky, AC; Wiltschke, C; Kramer, G; Marberger, M; Zielinski, CC
      Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    36. Russell-Jones, R
      Interferon-alpha therapy for melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    37. Yip, D; Strickland, AH; Karapetis, CS; Hawkins, CA; Harper, PG
      Immunomodulation therapy in colorectal carcinoma

      CANCER TREATMENT REVIEWS
    38. Baekke, J; Rytter, C; Mouridsen, H; Madsen, EL; Moholt, K; Bastholt, L
      A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma

      ACTA ONCOLOGICA
    39. Nocini, PF; Fior, A; Tolo, C; Bertossi, D
      Arteriovenous malformation of the nasal ala: A case report

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    40. Roebuck, DJ; Ahuja, AT
      Hemangioendothelioma of the parotid gland in infants: Sonography and correlative MR imaging

      AMERICAN JOURNAL OF NEURORADIOLOGY
    41. Maingon, P; Truc, G; Dalac, S; Barillot, I; Lambert, D; Petrella, T; Naudy, S; Horiot, JC
      Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation

      RADIOTHERAPY AND ONCOLOGY
    42. Kuhr, T; Eisterer, W; Apfelbeck, U; Linkesch, W; Bechter, O; Zabernigg, A; Geissler, K; Barbieri, G; Duba, C; Gastl, G; Thaler, J
      Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study

      LEUKEMIA RESEARCH
    43. Lehmann, S; Bengtzen, S; Broberg, U; Paul, C
      Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML

      LEUKEMIA RESEARCH
    44. Dearden, CE; Matutes, E; Catovsky, D
      Clinical overview of pentostatin (Nipent) use in lymphoid malignancies

      SEMINARS IN ONCOLOGY
    45. Foss, FM
      Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: Single-agent and combination studies

      SEMINARS IN ONCOLOGY
    46. Margolis, J; Vogelsang, G
      An old drug for a new disease: Pentostatin (Nipent) in acute graft-versus-host disease

      SEMINARS IN ONCOLOGY
    47. Fossa, SD
      Interferon in metastatic renal cell carcinoma

      SEMINARS IN ONCOLOGY
    48. Berg, WJ; Divgi, CR; Nanus, DM; Motzer, RJ
      Novel investigative approaches for advanced renal cell carcinoma

      SEMINARS IN ONCOLOGY
    49. Garzon, MC; Frieden, IJ
      Hemangiomas: When to worry

      PEDIATRIC ANNALS
    50. Tigrani, VS; Reese, DM; Small, EJ; Presti, JC; Carroll, PR
      Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: A retrospective analysis

      UROLOGY
    51. Tothova, E; Fricova, M; Kafkova, A; Stecova, N; Guman, T; Raffac, S; Hlebaskova, M
      Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia

      NEOPLASMA
    52. Thompson, WD; Li, WW; Maragoudakis, M
      The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies

      JOURNAL OF PATHOLOGY
    53. Sarrafizadeh, R; Trese, MT
      Ophthalmology update for the primary practitioner Part II. Therapeutic management of age-related macular degeneration

      DM DISEASE-A-MONTH
    54. Elias, L; Lew, D; Figlin, RA; Flanigan, RC; Thompson, ME; Triozzi, PL; Belt, RJ; Wood, DP; Rivkin, SE; Crawford, ED
      Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma - A southwest oncology group phase II study

      CANCER
    55. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    56. Negrier, S; Ollivier, L; Di Stefano-Louineau, D; Escudier, B; Savary, J; Lasset, C; Thiesse, P
      Response rate accuracy in oncology - Analysis of causes for variation

      BULLETIN DU CANCER
    57. Metry, DW; Hebert, AA
      Benign cutaneous vascular tumors of infancy - When to worry, what to do

      ARCHIVES OF DERMATOLOGY
    58. Orvidas, LJ; Kasperbauer, JL
      Pediatric lymphangiomas of the head and neck

      ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
    59. Cordel, N; Chosidow, O; Frances, C
      Cutaneous disorders associated with hepatitis C virus infection

      ANNALES DE MEDECINE INTERNE
    60. Lunel, F; Cacoub, P
      Treatment of autoimmune and extra-hepatic manifestations of HCV infection

      ANNALES DE MEDECINE INTERNE
    61. Kobayashi, H; Kobayashi, K
      Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    62. Walmsley, S; Northfelt, DW; Melosky, B; Conant, M; Friedman-Kien, AE; Wagner, B
      Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    63. Hernberg, M; Pyrhonen, S; Muhonen, T
      Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials

      JOURNAL OF IMMUNOTHERAPY
    64. Fujii, A; Yui-En, K; Ono, Y; Yamamoto, H; Gohji, K; Takenaka, A
      Preliminary results of the alternating administration of natural interferon-alpha and recombinant interferon-gamma for metastatic renal cell carcinoma

      BJU INTERNATIONAL
    65. Wilmer, A; Kaatz, M; Bocker, T; Wollina, U
      Tufted angioma

      EUROPEAN JOURNAL OF DERMATOLOGY
    66. Blei, F
      New clinical observations in hemangiomas

      SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
    67. Lam, NP
      Hepatitis C: Natural history, diagnosis, and management

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    68. Berg, WJ; Nanus, DM; Leung, A; Brown, KT; Hutchinson, B; Mazumdar, M; Xu, XC; Lotan, R; Reuter, VE; Motzer, RJ
      Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a

      CLINICAL CANCER RESEARCH
    69. Queirolo, P; Ponte, M; Gipponi, M; Cafiero, F; Peressini, A; Semino, C; Pietra, G; Lionetto, R; Vecchio, S; Ribizzi, I; Melioli, G; Sertoli, MR
      Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: A phase III pilot trial

      ANNALS OF SURGICAL ONCOLOGY
    70. Garcia, ED; Santolaya, R; Requena, T
      Treatment of malignant melanoma

      ANNALS OF PHARMACOTHERAPY
    71. Walker, PJ; Cooper, D; MacDonald, D
      Subglottic haemangioma: Controversies in management

      JOURNAL OF PAEDIATRICS AND CHILD HEALTH
    72. Sabaawy, HME; Ikehara, S; Adachi, Y; Quan, S; Feldman, E; Kancherla, R; Abraham, NG; Ahmed, T
      Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    73. Bielenberg, DR; Bucana, CD; Sanchez, R; Mulliken, JB; Folkman, J; Fidler, IJ
      Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta

      INTERNATIONAL JOURNAL OF ONCOLOGY
    74. Hausmaninger, H; Moser, R; Samonigg, H; Mlineritsch, B; Schmidt, H; Pecherstorfer, M; Fridrik, M; Kopf, C; Nitsche, D; Kaider, A; Ludwig, H
      Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: Final resultsof a randomised phase III study

      EUROPEAN JOURNAL OF CANCER
    75. Ravandi, F; Rytting, ME; Osmon, C; Braud, EL; Roach, RW; Edwards, K; Winn, R; Abbruzzese, JL; Pazdur, R
      Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer

      ANTI-CANCER DRUGS
    76. Ho, AD; Suciu, S; Stryckmans, P; De Cataldo, F; Willemze, R; Thaler, J; Peetermans, M; Dohner, H; Solbu, G; Dardenne, M; Zittoun, R
      Pentostatin in T-cell malignancies - a phase II trial of the EORTC

      ANNALS OF ONCOLOGY
    77. Enjolras, O
      Vascular tumors and vascular malformations: Are we at the dawn of a betterknowledge?

      PEDIATRIC DERMATOLOGY
    78. Soori, GS; Schulof, RS; Stark, JJ; Wiemann, MC; Honeycutt, PJ; Church, CK; DePriest, CB
      Continuous-infusion floxuridine and alpha interferon in metastatic renal cancer: A national biotherapy study group phase II study

      CANCER INVESTIGATION
    79. Bukowski, RM
      Chemoimmunotherapy of metastatic renal cell carcinoma

      CANCER INVESTIGATION
    80. De Clercq, E; Andrei, G; Balzarini, J; Hatse, S; Liekens, S; Naesens, L; Neyts, J; Snoeck, R
      Antitumor potential of acyclic nucleoside phosphonates

      NUCLEOSIDES & NUCLEOTIDES
    81. Motzer, RJ; Mazumdar, M; Bacik, J; Berg, W; Amsterdam, A; Ferrara, J
      Survival and prognostic stratification of 670 patients with advanced renalcell carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    82. Cangiano, T; Liao, J; Naitoh, J; Dorey, F; Figlin, R; Belldegrun, A
      Sarcomatoid renal cell carcinoma: Biologic behavior, prognosis, and response to combined surgical resection and immunotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    83. Mross, K; Scheulen, ME; Manegold, C; Westerhausen, M; Edler, L; Becher, R
      Phase II study with interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma - A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society

      ONKOLOGIE
    84. Upton, J; Coombs, CJ; Mulliken, JB; Burrows, PE; Pap, S
      Vascular malformations of the upper limb: A review of 270 patients

      JOURNAL OF HAND SURGERY-AMERICAN VOLUME
    85. Schulz, AS; Urban, J; Gessler, P; Behnisch, W; Kohne, E; Heymer, B
      Anaemia, thrombocytopenia and coagulopathy due to occult diffuse infantilehaemangiomatosis of spleen and pancreas

      EUROPEAN JOURNAL OF PEDIATRICS
    86. Elias, L; Binder, M; Mangalik, A; Clark, D; Morrison, B; Altobelli, KK; Smith, A
      Pilot trial of infusional 5-fluorouracil, interleukin-2, and subcutaneous interferon-alpha for advanced renal cell carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    87. Margolin, KA; Liu, PY; Unger, JM; Fletcher, WS; Flaherty, LE; Urba, WJ; Hersh, EM; Hutchins, LE; Sosman, JA; Smith, JW; Weiss, GR; Sondak, VK
      Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    88. Lunel, F; Cacoub, P
      Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection

      JOURNAL OF HEPATOLOGY
    89. Mangia, A; Andriulli, A; Zenarola, P; Lomuto, M; Cascavilla, I; Quadri, R; Negro, F
      Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients

      JOURNAL OF MEDICAL VIROLOGY
    90. Mueller, BU; Mulliken, JB
      The infant with a vascular turner

      SEMINARS IN PERINATOLOGY
    91. Kim, YH; Hoppe, RT
      Mycosis fungoides and the Sezary syndrome

      SEMINARS IN ONCOLOGY
    92. Miller, K
      Renal cell carcinoma - Guidelines for diagnosis and treatment

      UROLOGIA INTERNATIONALIS
    93. Kaban, LB; Mulliken, JB; Ezekowitz, RA; Ebb, D; Smith, PS; Folkman, J
      Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a

      PEDIATRICS
    94. Myhr, KM; Riise, T; Lilleas, FEG; Beiske, TG; Celius, EG; Edland, A; Jensen, D; Larsen, JP; Nilsen, R; Nortvedt, MW; Smievoll, AI; Vedeler, C; Nyland, HI
      Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis

      NEUROLOGY
    95. Caturla, JT; Soler, RS; Larriba, JLG
      Immunological treatment of renal cancer

      MEDICINA CLINICA
    96. Thompson, WD; Li, WW; Maragoudakis, M
      The clinical manipulation of angiogenesis: Pathology, side-effects, surprises, and opportunities with novel human therapies

      JOURNAL OF PATHOLOGY
    97. Krengel, S; Tebbe, B; Goerdt, S; Stoffler-Meilicke, M; Orfanos, CE
      Hepatitis C virus-associated dermatoses: a review

      HAUTARZT
    98. Akpek, G; Koh, HK; Bogen, S; O'Hara, C; Foss, FM
      Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma

      CANCER
    99. Dorval, T; Negrier, S; Chevreau, C; Avril, MF; Baume, D; Cupissol, D; Oskam, R; de Peuter, R; Vinke, J; Herrera, L; Escudier, B
      Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma

      CANCER
    100. Hudes, GR; Lipsitz, S; Grem, J; Morrisey, M; Weiner, L; Kugler, JW; Benson, A
      A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma - AnEastern Cooperative Oncology Group Study (E5292)

      CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 09:58:46